The presentation is largely rehashed and was probably released to blunten the impact of the half yearly. It doesn't tell us precisely how we will commercialise BA. Management need to start responding to emails and answer sh questions about vibrovein. Last I heard this would be ready for partnering by oct. No mention about it in conversations either.
Ann: Investor Presentation , page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)